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abstract: Objectives: The ex vivo maintenance of haematopoietic stem/progenitor cells (HSPCs) is crucial to 
ensure a sufficient supply of functional cells for research or therapeutic applications. However, when exposed to 
reactive oxygen species (ROS) in a normoxic microenvironment, HSPCs exhibit genomic instability which may 
diminish their quantity and quality. This study aimed to investigate the role of N-acetylcysteine (NAC) supple-
mentation on the oxidative stress levels, genotoxicity and lineage commitment potential of murine haematopoietic 
stem/progenitor cells (HSPCs). Methods: This study was carried out at the Universiti Kebangsaan Malaysia, 
Kuala Lumpur, Malaysia, between June 2016 and July 2017. Bone marrow cells were isolated from nine mice and 
cultured in a growth medium. Various concentrations of NAC between 0.125–2 µM were added to the culture for 
48 hours; these cells were then compared to non-supplemented cells harvested from the remaining three mice 
as the control group. A trypan blue exclusion test was performed to determine cell viability, while intracellular 
ROS levels and genotoxicity were determined by hydroethidine staining and comet assay, respectively. The lineage 
commitment potential of erythroid, myeloid and pre-B-lymphoid progenitor cells was evaluated via colony-forming 
cell assay. Results: NAC supplementation at 0.25, 0.5 and 2 µM significantly increased cell viability (P <0.050), 
while intracellular ROS levels significantly decreased at 0.25 and 0.5 µM (P <0.050). Moreover, DNA damage was 
significantly reduced at all NAC concentrations (P <0.050). Finally, the potential lineage commitment of the cells 
was not significantly affected by NAC supplementation (P >0.050). Conclusion: The findings of this study indicate 
that NAC supplementation may potentially overcome the therapeutic limitations of ex vivo-maintained HSPCs.
Keywords: Hematopoietic Stem Cells; N-acetylcysteine; Reactive Oxygen Species; DNA Damage; Cell Lineage.
امللخ�ص: الهدف: اإن �شيانة اخلاليا اجلذعية املكونة للدم واخلاليا اجلذرية بالطريقة احليوية خارج اجل�شم يعترب �رضوريًا ل�شمان توفري 
ما يكفي من اخلاليا املختربية احليوية والقابلة لالإ�شتخدام لغر�ض الأبحاث اأو لالإ�شتخدامات العالجية، لكن عند تعر�ض مثل هذه اخلاليا 
لعنا�رضالأك�شجني التفاعلية يف بيئة متعادلة، تظهر اخلاليا الدموية اجلذعية حالة عدم ا�شتقرار جيني مما قد يقلل من عددها وجودتها، 
وال�شمية  التاأك�شدي  الإجهاد  م�شتويات  يف   )N-acetylcysteine(-شي�شتني� الأ�شيتيل  مكمالت  دور  معرفة  اإىل  الدرا�شة  هذه  هدفت  لذلك 
الوراثية وقابلية عودة الإنت�شاب للخاليا اجلذعية امل�شتخل�شة خارج اجل�شم يف الفئران اأو اخلاليا اجلذرية. الطريقة: اأجريت هذه الدرا�شة 
يف جامعة كيباجن�شان يف كوال ملبور-ماليزيا، يف الفرتة بني يونيو 2016 ويوليو 2017، مت خاللها عزل خاليا النخاع العظمي ا�شتخرجت 
من عدد ت�شعة الفئران ومت تربية اخلاليا يف و�شط ا�شتنبات، متت اإ�شافة الأ�شيتيل �شي�شتني برتاكيز ترتاوح بني 2–0.125 ميكرومرت للو�شط 
ال�شتنباتي وملدة 48 �شاعة، ثم متت مقارنة هذه اخلاليا بخاليا مت ا�شتخال�شها من الفئران الثالثة املتبقية دون اأن يتم ا�شافة اأي مركبات 
لها لتقوم بدور جمموعة ال�شبط، مت اإجراء اختبار ا�شتبعاد با�شتخدام الرتيبان الأزرق لتحديد حيوية اخللية، يف حني مت حتديد م�شتويات 
مت  كما  املذنبي،  املعايرة  فح�ض  طريق  عن  اجلينية  وال�شميِّة  هيدرواإثيدين  �شبغة  طريق  عن  اخلاليا  داخل  التفاعلية  عنا�رضالأك�شجني 
اأو الأ�شل ما قبل التمايز اللمفاوي نوع-ب عن طريق اختبار معايرة خلية  تقييم اإمكانية التزام اخلاليا الإنت�شابي اإىل الأ�شل النخاعي 
مكونة لكتلة ال�شتنبات. النتائج: مكمالت الأ�شيتيل �شي�شتني بالرتاكيز 0.25، 0.5 و 2 ميكرومرت اأدت اإىل زيادة ملحوظة يف حيوية اخللية 
0.5 ميكرومرت  و  الرتاكيز 0.25  التفاعلية داخل اخلاليا ب�شكل ملحوظ يف  انخف�شت م�شتويات عنا�رضالأك�شجني  )P >0.050(، يف حني 
.)P >0.050( عالوة على ذلك، لوحظ انخفا�ض معدل تلف احلم�ض النووي ب�شكل ملحوظ يف جميع تركيزات الأ�شيتيل �شي�شتني ،)P >0.050( 
واأخرًيا، مل يتاأثر التزام الن�شب املحتمل للخاليا بدرجة كبرية بعد ا�شافة الأ�شيتيل �شي�شتني )P >0.050(. اخلال�صة: اإن نتائج هذه الدرا�شة 
للدم  املكونة  اجلذعية  للخاليا  العالجي  ال�شتخدام  التقليل من حمدودية  ي�شاهم يف  قد  �شي�شتني  الأ�شيتيل  ا�شافة مكمالت  اأن  اإىل  ت�شري 
واخلاليا اجلذرية امل�شتنبتة حيويًا خارج اجل�شم.
الكلمات املفتاحية: اخلاليا اجلذعية املكونة للدم؛ الأ�شيتيل �شي�شتني؛ عنا�رض الك�شجني التفاعلية؛ تلف احلم�ض النووي؛ انت�شاب اخللية. 
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Haematopoietic stem/progenitor cells (HSPCs) constitute a highly promising avenue for medical treatment and research; however, 
their potency is determined by their ability to self-
renew and differentiate into multiple lineages.1,2 Prior 
to clinical use, stem cells often undergo ex vivo exp-
ansion—in which the cells are harvested from an 
intact organism and directly cultured in a laboratory 
setting without any biological modification—so as to 
ensure a sufficient number of functional cells can be 
harvested.3,4 In contrast, in vitro stem cells are obtained 
from a repository or cell lines that have been genetically 
transformed. 
Physiologically, HSPCs are found in the bone 
marrow under conditions of low oxygen tension 
(1–4%).5,6 This microenvironment is known as a hypoxic 
niche and plays a critical role in regulating HSPC expan- 
sion and cellular levels of reactive oxygen species (ROS). 
However, the ex vivo expansion and maintenance of 
HSPCs requires that the cells adjust to normoxic condi- 
tions with greater oxygen tension (21%) and enhanced 
ROS production.7 These conditions can interfere with 
the self-renewal capacities of HSPCs and promote 
differentiation, leading to premature senescence and 
therefore fewer functional stem cells for transplant-
ation.7,8 Moreover, excessive ROS production can result 
in genomic instability, thus compromising the quality 
of the stem cells and limiting their therapeutic 
potential.9,10 Numerous efforts have been made to over- 
come the limitations associated with the ex vivo expan- 
sion and maintenance of HSPCs, including genetic 
modification, co-culturing with feeder cells and the 
addition of a cytokine cocktail; however, these approaches 
have various drawbacks.11–15 
Recent research has indicated that the use of anti-
oxidants may be a promising ex vivo expansion tech-
nique due to their role as excess ROS scavengers.10,16,17 
N-acetylcysteine (NAC) is an antioxidant generated 
from the thiol-containing amino acid cysteine and is 
the precursor for glutathione.16,18 At a concentration 
of 0.1 µM, NAC supplementation has been reported 
to preserve the chromosomal stability of cultured 
HSPCs.19,20 Nonetheless, while previous studies have 
documented the benefits of NAC supplementation in 
maintaining haematopoiesis, few have examined their 
use in the ex vivo maintenance of HSPCs or focused 
on oxidative-mediated cellular damage and lineage 
commitment.21,22 This study therefore aimed to determ- 
ine the effect of NAC supplementation on the survi-
vability, DNA integrity, cellular ROS levels and lineage 
commitment potential of ex vivo HSPCs.
Methods
This study was carried out at the Universiti Kebangsaan 
Malaysia, Kuala Lumpur, Malaysia, between June 2016 
and July 2017. A total of 12 imprinting control region 
male mice were included in the study, all of which 
were 10 weeks old and weighed 30–35 g. Bone marrow 
cells from three mice were each allocated to an 
experimental group, while bone marrow cells from the 
remaining three mice constituted the control group. 
Each experiment to determine cell viability, cellular ROS 
production and DNA integrity status was repeated in 
triplicate using 1 × 106 cells from a different mouse in 
each group, while 1 × 106 cells were used to determine 
the lineage commitment potential of erythroid and 
pre-B lymphoid progenitor cells and 1 × 105 cells were 
used for myeloid progenitor cells.
Each mouse was killed by cervical dislocation and 
the tibia and femur were isolated. Pre-cooled Gibco® 
Dulbecco’s Modified Eagle’s medium (DMEM; Thermo- 
Fisher Scientific, Waltham Massachusetts, USA) was 
flushed over the bones using a 21 gauge needle and 
a 10 mL syringe. Harvested cells were subsequently 
filtered through a 40 µM cell strainer, centrifuged 
at 2,500 rpm for 7 minutes and resuspended in a 
growth medium consisting of DMEM supplemented 
with 10% fetal bovine serum and 1% penicillin-
streptomycin (ThermoFisher Scientific). A cocktail of 
growth factors consisting of 100 ng/mL of stem cell 
factor, 10 ng/mL of interleukin (IL)-6 and 5 ng/mL 
of IL-3 was then added to the culture (Miltenyi Biotec, 
Bergisch Gladbach, Germany). Approximately 1 × 107 
bone marrow cells were obtained from each mouse.10 
The cells were then maintained in a 5% carbon 
dioxide (CO2) incubator at 37 
°C for 24 hours. Sub-
sequently, NAC was added to cells in the experi-
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mental groups at various concentrations (0.125, 0.25, 
0.5, 1 or 2 µM) for an additional 48 hours.20 Cells with- 
out NAC supplementation were used as the control 
group for all parameters. However, an additional positive 
control group was used to analyse DNA damage, for 
which the cells received 100 µM of hydrogen peroxide 
for 30 minutes in a 5% CO2 incubator at 37 
°C.
A trypan blue exclusion test was performed to 
quantify the number of viable cells in samples from 
both the experimental and control groups. The cells 
were seeded into 24-well plates containing HSPC growth 
medium at a density of 1 × 106 cells/mL. The cell susp-
ension cultures were then diluted at a ratio of 1:1 with 
0.4% trypan blue solution, after which the number of 
viable cells were counted using a microscope. Cellular 
ROS production was determined as follows. The cells 
were harvested and centrifuged at 2,500 rpm for 
7 minutes. Approximately 1 × 106 cells were then resus-
pended in 1 mL of prewarmed unenriched DMEM 
medium, stained with 10 mM of hydroethidine (HE; 
Sigma-Aldrich Corp., St. Louis, Missouri, USA) and 
incubated in the dark for 30 minutes in a 5% CO2 incub-
ator at 37 °C. The HE-stained cells were then washed 
twice and centrifuged at 2,500 rpm for 5 minutes at 
4 °C. The supernatant was discarded and the cell pellets 
resuspended in 500 μL of cold phosphate-buffered 
saline (PBS).10 Subsequently, the intensity of HE fluor-
escence was measured using the BD FACSCanto™ 
II flow cytometry system (BD Biosciences, San Jose, 
California, USA), with ROS production expressed as 
the percentage of ROS-producing cells.
The potentially genotoxic effect of NAC supple-
mentation was assessed via alkaline comet assay using 
microgel electrophoresis.23 This technique was employed 
due to its improved detection sensitivity in comparison 
to direct quantification methods which do not supply 
current or voltage after the unwinding and neutral-
isation of the DNA.23,24 A total of 1 × 106/mL of cells 
from each group were harvested and centrifuged at 
2,500 rpm for 5 minutes at 4 °C. The cells were then 
washed twice in a calcium- and magnesium-free PBS 
and recentrifuged at 1,200 rpm for 5 minutes at 4 °C. 
The cell pellets were mixed with 70 μL of 0.6% normal 
melting point agarose (NMPA) gel (Sigma-Aldrich 
Corp.). The mixture was loaded onto a full-frosted 
microscope slide, topped with a coverslip and left to 
cool on ice for 15 minutes. Once the gel had solidified, 
the coverslip was gently removed and a layer of 80 μL 
of low melting point agarose gel (Sigma-Aldrich 
Corp.) was added on top of the NMPA layer. Next, 
the solidified slide was immersed overnight into a lysis 
buffer consisting of 2.5 M of sodium chloride, 100 mM 
of disodium ethylenediaminetetraacetic acid, 10 mM 
of tris(hydroxymethyl)aminomethane and 1% Triton™ 
X-100 (Sigma-Aldrich Corp.) at 4 °C. The slides were 
then equilibrated in an electrophoresis buffer at 300 mA 
for 20 minutes and then 25 V for 20 minutes, before 
being rinsed three times in a neutralisation buffer for 
5 minutes each rinse. Thereafter, the slides were stained 
with 25 μL of ethidium bromide (ThermoFisher Sci-
entific) at 20 μg/mL and viewed under a Leica fluoresc-
ence microscope (Meyers Instruments, Houston, Texas, 
USA) using a 590 nm excitation filter. The amount of 
DNA in the tail and the tail moment of 100 cells per 
slide was subsequently analysed using CometScore 
software (TriTek Technologies Inc., Annandale, Virginia, 
USA). 
The lineage commitment potential of the eryth-
roid, myeloid and lymphoid progenitor cells was determ- 
ined via colony-forming cell assay using three types of 
methylcelluloses (MethoCult™ GF M3334, GF M3534 
and M3630, STEMCELL™ Technologies Inc., Van-
couver, Canada). These methylcelluloses were used to 
support the growth of colony-forming unit (CFU)-
erythroid, CFU-granulocytes (G), CFU-macrophages 
(M), CFU-GM and CFU-lymphoid (CFU-pre-B) cells. 
Myeloid progenitor cells were classified as CFU-G, 
CFU-M or CFU-GM, based on a morphological analy-
sis of the colonies derived from the assay. The plating 
density was optimised at 2 × 105 cells/mL for CFU-
GM, 1 × 106 cells/mL for CFU-E and 1 × 106 cells/mL 
for CFU-pre-B. The cell and methylcellulose mixture 
was then placed into a six-well plate and incubated at 
37 °C for either seven (for CFU-E and CFU-pre-B) or 
14 (for CFU-GM) days. The number of colonies was 
then determined via light microscope observation.
Statistical analysis was conducted using the Statist- 
ical Package for the Social Sciences (SPSS), Version 22.0 
(IBM Corp., Armonk, New York, USA). The results 
were presented as means ± standard error and displayed 
graphically in the form of histograms or plot diagrams. 
A P value of <0.050 was considered statistically signif-
icant. A Shapiro-Wilk test was conducted to determine 
the normality of the data. Where the assumption of 
normality was not rejected, an independent Student’s 
t-test was employed to test the differences in studied 
parameters between NAC-supplemented and control 
cell groups.
All procedures involving the use of laboratory 
animals in this study were reviewed and approved by 
the Animal Ethics Committee of the Universiti Keban-
gsaan Malaysia (#FSK/2016/ZARIYANTEY/27-JULY/ 
773-JULY-2016-JUNE-2017-AR-CAT2).
Results
In terms of cell viability, there were significantly more 
viable cells noted among HSPCs supplemented with 
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0.25 μM (8.47 ± 0.29 × 105 cells/mL; P = 0.001), 0.5 μM 
(8.32 ± 0.72 × 105 cells/mL; P = 0.014) and 2 μM (6.37 
± 0.16 × 105 cells/mL; P = 0.011) of NAC in comp-
arison to the control group (5.18 ± 0.20 × 105 cells/mL) 
[Figure 1]. Cellular ROS production was also signif-
icantly lower among cells supplemented with 0.25 µM 
(10.23 ± 0.47%; P = 0.011) and 0.5 µM (9.83 ± 1.43%; 
P = 0.040) of NAC, as compared to the control group 
(12.20 ± 1.01%) [Figure 2].
Among NAC-supplemented cells, DNA damage 
was significantly suppressed, with the percentage of 
DNA in the tail being 7.65 ± 0.40% (P = 0.048), 6.89 
± 0.08% (P = 0.022) and 5.96 ± 0.98% (P = 0.027) 
for concentrations of 0.25, 0.5 and 2 µM of NAC, 
respectively, in comparison to the control group 
(11.08 ± 1.15%) [Figure 3A]. In addition, there was 
also a significant reduction in the tail moment of 
NAC-supplemented cells at concentrations of 0.25 µM 
(0.65 ± 0.06 arbitrary units [AUs]; P = 0.002), 0.5 µM 
(0.71 ± 0.12 AUs; P = 0.003) and 2 µM (0.34 ± 0.03 AUs; 
P = 0.001), as compared to the control group (2.04 ± 0.10 
AUs) [Figure 3B]. 
Regarding the effect of NAC supplementation 
on the lineage commitment potential of erythroid, 
lymphoid and myeloid progenitor cells, there was no 
significant difference in colony count for CFU-GM at 
0.25 µM (82.67 ± 11.05 × 105 cells/mL; P = 0.075), 0.5 µM 
(77.00 ± 12.74 × 105 cells/mL; P = 0.063) and 2 µM 
(69.33 ± 18.67 × 105 cells/mL; P = 0.072) of NAC supple-
mentation, in comparison to the control group (128.67 
± 15.76 × 105 cells/mL). For CFU-G, the control group 
again demonstrated the highest number of colonies 
(61.67 ± 7.88 × 105 cells/mL); however, this difference 
was not significant in comparison to cells supplemented 
with 0.25 µM (36.00 ± 9.64 × 105 cells/mL; P = 0.108), 
Figure 3: Histograms showing the effect of 48-hour N-acetylcysteine (NAC) supplementation on (A) the percentage of 
tail DNA and (B) the tail moment of ex vivo haematopoietic stem/progenitor cells. Cells treated with 100 µM of hydrogen 
peroxide served as a positive control group for the purposes of assay validation. All values represent means ± standard 
error.
H2O2 = hydrogen peroxide; NAC = N-acetylcysteine; AUs = arbitrary units.
*Significant difference in comparison to the control group (P <0.050).
Figure 1: Plot diagram showing the effect of 48-hour 
N-acetylcysteine (NAC) supplementation on the viab-
ility of ex vivo haematopoietic stem/progenitor cells. All 
values represent means ± standard error.
NAC = N-acetylcysteine.
*Significant difference in comparison to the control group (P <0.050).
Figure 2: Histogram showing the effect of 48-hour 
N-acetylcysteine supplementation on the level of react-
ive oxygen species in ex vivo haematopoietic stem/pro-
genitor cells. All values represent means ± standard error.
ROS = reactive oxygen species; NAC = N-acetylcysteine.
*Significant difference in comparison to the control group (P <0.050).
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0.5 µM (50.33 ± 12.60 × 105 cells/mL; P = 0.393) 
or 2 µM (36.67 ± 6.69 × 105 cells/mL; P = 0.073) of NAC. 
Similar results were noted for CFU-M, with the highest 
colony count identified in the control group (37.00 ± 
7.81 × 105 cells/mL), followed by cells supplemented 
with 0.5 µM (30.33 ± 10.41 × 105 cells/mL; P = 0.636), 
0.25 μM (27.00 ± 6.56 × 105 cells/mL; P = 0.382) and 
2 µM (23.33 ± 6.44 × 105 cells/mL; P = 0.248) and of 
NAC [Figure 4A].
Similarly, no significant differences in CFU-E 
counts were noted between NAC-supplemented cells 
at 0.25 µM (84.30 ± 2.91 × 106 cells/mL; P = 0.330), 
0.5 µM (65.00 ± 14.11 × 106 cells/mL; P = 0.177) and 
2 µM (68.7 ± 7.84 × 106 cells/mL; P = 0.073) and those 
in the control group (88.30 ± 2.19 × 106 cells/mL). The 
colony counts for CFU-pre-B also showed no signif-
icant difference between the control group (47.00 ± 
6.08 × 106 cells/mL) and the NAC-supplemented cells at 
concentrations of 0.25 µM (48.00 ± 4.58 × 106 cells/mL; 
P = 0.902), 0.5 µM (42.67 ± 11.05 × 105 cells/mL; P = 0.748)
and 2 µM (34.00 ± 11.68 × 106 cells/mL; P = 0.379) 
[Figure 4B].
Discussion
Maintenance of ROS production at optimum levels is 
crucial to regulate the intracellular and extracellular 
signalling pathways involved in the self-renewal and 
differentiation activities of HSPCs.5,25 Excessive levels of 
ROS can trigger cells to undergo differentiation rather 
than self-renewal, while too few ROS can inhibit prolif- 
eration.26 The production of ROS is closely related to 
cellular respiration among metabolically inactive HSPCs 
in a dormant state.6–8 Inversely, when HSPCs are placed 
under stress, such as in normoxic conditions, mitochon- 
drial activities are elevated and contribute to elevated 
ROS production.5,27 Previous studies have reported that 
altering the microenvironment of HSPCs to normoxic 
conditions can lead to a reduction in the number of 
HSPCs due to an increase in differentiation, premature 
ageing and apoptosis.7,28
In the current study, NAC supplementation was 
found to enhance the survivability of HSPCs at specific 
concentrations (0.25, 0.5 and 2 μM). Moreover, HSPCs 
which did not receive NAC supplementation showed 
the lowest cell viability. This finding is in accordance 
with a previous study which reported the beneficial 
effects of NAC in minimising cytotoxicity among 
irradiated rat bone marrow cells by improving the 
mitotic index.22 Moreover, the current study found 
that NAC supplementation at concentrations of 0.25 
and 0.5 µM suppressed cellular ROS levels; this finding 
is in agreement with those of a previous study.5 Altinoz 
et al. also demonstrated the protective role of NAC 
against acrylamide-induced oxidative stress in rats.29 It 
can therefore be postulated that optimum ROS levels 
play a role in promoting survivability and maintenance 
in HSPCs.
Increased ROS production can overload the cellular 
antioxidant capacity, exposing macromolecules such as 
DNA, ribonucleic acid and proteins to ROS attack.30 
This can lead to the accumulation of DNA damage and 
premature cell ageing during long-term culturing.26 In 
the present study, NAC supplementation was found to 
have a genoprotective function, as evidenced by the 
remarkably low levels of DNA damage observed in 
NAC-supplemented cells as compared to those in the 
control group. Other studies have reported that NAC 
has the ability to reverse DNA damage in rat models with 
irradiated bone marrow, hepatopulmonary syndrome 
and acrylamide-induced genotoxicity.21,22,29
The current study also investigated the effects of 
NAC supplementation on the lineage commitment 
potential of erythroid, myeloid and lymphoid progen-
itor cells and found that NAC supplementation did 
not affect the lineage commitment potential of these 
respective progenitors. To the best of the authors’ 
knowledge, no previous studies have been conducted 
Figure 4: Histograms showing the effect of 48-hour N-acetylcysteine supplementation on the lineage commitment 
potential of ex vivo haematopoietic stem/progenitor cells. All values represent means ± standard error.
CFU = colony-forming unit; M = macrophages; G = granulocytes; E = erythroid; Pre-B = lymphoid; NAC = N-acetylcysteine.
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to assess the lineage commitment potential among 
NAC-supplemented ex vivo HSPCs. However, a 
previous study reported that the administration of 
100 µM of NAC for four weeks in mice enhanced the 
repopulation of myeloid progenitors, as evidenced by 
increased colony counts.31 
As previously discussed, HSPCs are at greater risk 
of oxidative stress exposure following ex vivo main- 
tenance, a factor which can impair their usefulness in 
terms of both quality and quantity.7–10 Overall, the 
results of the present study indicate that NAC may 
have a potential role as an antioxidant supplement for 
the optimal expansion and maintenance of HSPCs, 
without compromising their potential for self-renewal 
and multilineage differentiation. However, further 
research is necessary to support these findings, esp-
ecially considering the small sample size of the current 
study necessitated by financial constraints and the short 
study duration. Nevertheless, despite these limitations, 
these findings may serve as a platform for future 
research exploring the use of antioxidants in HSPC 
expansion and maintenance. 
Conclusion
The findings of this study support the use of NAC 
supplementation for the ex vivo maintenance of HSPCs 
by reducing oxidative stress and maintaining their self-
renewal and multilineage differentiation properties 
without genotoxic effects. However, further research 
with a larger sample size is needed to investigate the 
role of NAC supplementation on the oxidative status 
and genomic stability of HSPCs following long-term 
ex vivo maintenance.
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